Prophylactic Irradiation of the Contralateral Breast for <i>BRCA</i> Carriers With Early Breast Cancer
This nonrandomized phase 2 clinical trial examines contralateral breast cancer risk reduction in women who choose radiation therapy or surveillance rather than mastectomy.
Authors
- Ora Rosengarten (ORCID: https://orcid.org/0009-0000-9274-1866)
- Raphael Catane
- Diana Matceyevsky
- David Geffen (ORCID: https://orcid.org/0000-0003-0489-2870)
- Ella Evron (ORCID: https://orcid.org/0000-0002-1003-5042)
- Benjamin W. Corn (ORCID: https://orcid.org/0000-0002-2881-0326)
- Orit Kaidar‐Person (ORCID: https://orcid.org/0000-0003-4023-1869)
- Hadassah Goldberg
- M. Raphael Pfeffer
- Merav A. Ben David (ORCID: https://orcid.org/0000-0002-4928-3529)
- Roxolyana Abdah‐Bortnyak
Institutions
- Ben-Gurion University of the Negev (IL)
- Tel Aviv University (IL)
- Hebrew University of Jerusalem (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Sheba Medical Center (IL)
- Western Galilee Hospital (IL)
- Kaplan Medical Center (IL)
- Assuta Medical Center (IL)
- Soroka Medical Center (IL)
- Rambam Health Care Campus (IL)
- Shaare Zedek Medical Center (IL)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1001/jamaoncol.2025.0901
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00